QGEN241220P50000
- 0.00
- 0.000.00%
Qiagen NV Newsroom
Qiagen N.V.'s (NYSE:QGEN) Intrinsic Value Is Potentially 43% Above Its Share Price
Innovations Support QIAGEN Shares Despite Macroeconomic Concerns
Morgan Stanley Lists Hedge Funds' Largest Q3 Ownership Increases in Russell 1000 Stocks
Syros Pharmaceuticals Gave Notice To Qiagen Manchester Limited Of Its Election To Terminate The Master Collaboration Agreement Dated March 7, 2022
Catalyst Watch: Nvidia Earnings, Microsoft Ignite, Crypto Confidence, and P&G Event
QGEN Collaborates With McGill University Centre: Stock to Gain?
QIAGEN Collaborates With McGill University to Advance Microbiome Research
UBS Maintains Qiagen NV(QGEN.US) With Hold Rating
These 4 Measures Indicate That Qiagen (NYSE:QGEN) Is Using Debt Safely
Qiagen NV | 6-K: Report of foreign private issuer (related to financial reporting)
Stifel Maintains Qiagen NV(QGEN.US) With Hold Rating, Maintains Target Price $45
Qiagen (QGEN) Receives a Hold From Stifel Nicolaus
TD Cowen Maintains Qiagen NV(QGEN.US) With Hold Rating, Cuts Target Price to $49
Express News | Qiagen NV : Morgan Stanley Raises Target Price to $50 From $49
Is There An Opportunity With Qiagen N.V.'s (NYSE:QGEN) 31% Undervaluation?
Deutsche Bank Maintains Qiagen NV(QGEN.US) With Buy Rating
QIAGEN Stock Flat Post Q3 Earnings & Revenue Beat, 2024 EPS View Up
Qiagen 3Q EPS 44c >QGEN
Qiagen 3Q Sales $502M >QGEN
Express News | QIAGEN Reaffirms FY24 Sales Of At Least $1.985B Vs $1.98B Est.; Increases EPS Guidance From $2.10 CER To At Least $2.19 CER Vs $2.15 Est